Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
THRX > SEC Filings for THRX > Form 8-K on 17-Jun-2014All Recent SEC Filings

Show all filings for THERAVANCE INC

Form 8-K for THERAVANCE INC


17-Jun-2014

Other Events


Item 8.01 Other Events

The conversion rate adjustment with respect to our 2.125% Convertible Subordinated Notes due 2023 (the "Notes") that results from our spin-off of Theravance Biopharma, Inc. ("Theravance Biopharma) is based on the ten consecutive trading day period that ended on June 16, 2014 (the "Spin-Off Valuation Period"). Based on the average of the closing prices of our common stock and of Theravance Biopharma ordinary shares over the Spin-Off Valuation Period, the conversion rate of 46.9087 shares of our common stock for each $1,000 principal amount of Notes will become effective on June 17, 2014. Prior to the spin-off, the conversion rate for the Notes was 35.9903 shares of our common stock for each $1,000 principal amount of Notes.


  Add THRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for THRX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.